204 related articles for article (PubMed ID: 22906430)
1. Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotype-genotype correlation in Japanese patients with pachydermoperiostosis.
Sasaki T; Niizeki H; Shimizu A; Shiohama A; Hirakiyama A; Okuyama T; Seki A; Kabashima K; Otsuka A; Ishiko A; Tanese K; Miyakawa S; Sakabe J; Kuwahara M; Amagai M; Okano H; Suematsu M; Kudoh J
J Dermatol Sci; 2012 Oct; 68(1):36-44. PubMed ID: 22906430
[TBL] [Abstract][Full Text] [Related]
2. Identification of the Mutations in the Prostaglandin Transporter Gene, SLCO2A1 and Clinical Characterization in Korean Patients with Pachydermoperiostosis.
Lee S; Park SY; Kwon HJ; Lee CH; Kim OH; Rhee Y
J Korean Med Sci; 2016 May; 31(5):735-42. PubMed ID: 27134495
[TBL] [Abstract][Full Text] [Related]
3. Pachydermoperiostosis of the complete type: A novel missense mutation c.101T > C in the SLCO2A1 gene.
Ma W; Guo S; Li Y; Li Z
Eur J Med Genet; 2017 Aug; 60(8):433-436. PubMed ID: 28602931
[TBL] [Abstract][Full Text] [Related]
4. Three novel mutations in the SLCO2A1 gene in two Chinese families with primary hypertrophic osteoarthropathy.
Cheng R; Li M; Guo Y; Yao Y; Gao C; Yao Z
Eur J Dermatol; 2013; 23(5):636-9. PubMed ID: 24153155
[TBL] [Abstract][Full Text] [Related]
5. Two novel mutations in the SLCO2A1 gene in a Chinese patient with primary hypertrophic osteoarthropathy.
Zhang Z; He JW; Fu WZ; Zhang CQ; Zhang ZL
Gene; 2014 Jan; 534(2):421-3. PubMed ID: 24185079
[TBL] [Abstract][Full Text] [Related]
6. Inactivating mutation in the prostaglandin transporter gene, SLCO2A1, associated with familial digital clubbing, colon neoplasia, and NSAID resistance.
Guda K; Fink SP; Milne GL; Molyneaux N; Ravi L; Lewis SM; Dannenberg AJ; Montgomery CG; Zhang S; Willis J; Wiesner GL; Markowitz SD
Cancer Prev Res (Phila); 2014 Aug; 7(8):805-12. PubMed ID: 24838973
[TBL] [Abstract][Full Text] [Related]
7. Pachydermoperiostosis: The value of molecular diagnosis.
Seta V; Capri Y; Battistella M; Bagot M; Bourrat E
Ann Dermatol Venereol; 2017 Dec; 144(12):799-803. PubMed ID: 28916395
[TBL] [Abstract][Full Text] [Related]
8. Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy.
Zhang Z; Xia W; He J; Zhang Z; Ke Y; Yue H; Wang C; Zhang H; Gu J; Hu W; Fu W; Hu Y; Li M; Liu Y
Am J Hum Genet; 2012 Jan; 90(1):125-32. PubMed ID: 22197487
[TBL] [Abstract][Full Text] [Related]
9. Identification of mutations in the prostaglandin transporter gene SLCO2A1 and phenotypic comparison between two subtypes of primary hypertrophic osteoarthropathy (PHO): A single-center study.
Hou Y; Lin Y; Qi X; Yuan L; Liao R; Pang Q; Cui L; Jiang Y; Wang O; Li M; Dong J; Xia W
Bone; 2018 Jan; 106():96-102. PubMed ID: 28963081
[TBL] [Abstract][Full Text] [Related]
10. Involvement of prostaglandin E2 in the first Japanese case of pachydermoperiostosis with HPGD mutation and recalcitrant leg ulcer.
Nakazawa S; Niizeki H; Matsuda M; Nakabayashi K; Seki A; Mori T; Tokura Y
J Dermatol Sci; 2015 May; 78(2):153-5. PubMed ID: 25757862
[No Abstract] [Full Text] [Related]
11. Eicosanoid profiling in patients with complete form of pachydermoperiostosis carrying SLCO2A1 mutations.
Oiwa T; Ishibashi M; Okuno T; Ohba M; Endo Y; Uozumi R; Ghazawi FM; Yoshida K; Niizeki H; Yokomizo T; Nomura T; Kabashima K
J Dermatol; 2021 Sep; 48(9):1442-1446. PubMed ID: 34114674
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the SLCO2A1 gene and primary hypertrophic osteoarthropathy: a clinical and biochemical characterization.
Zhang Z; He JW; Fu WZ; Zhang CQ; Zhang ZL
J Clin Endocrinol Metab; 2013 May; 98(5):E923-33. PubMed ID: 23509104
[TBL] [Abstract][Full Text] [Related]
13. A novel homozygous mutation in the SLCO2A1 gene causing pachydermoperiostosis: Efficacy of hydroxychloroquine treatment.
Alessandrella A; Della Casa R; Alessio M; Puente Prieto J; Strisciuglio P; Melis D
Am J Med Genet A; 2018 May; 176(5):1253-1257. PubMed ID: 29681086
[TBL] [Abstract][Full Text] [Related]
14. Pachydermoperiostosis in an African patient caused by a Chinese/Japanese SLCO2A1 mutation-case report and review of literature.
Madruga Dias JA; Rosa RS; Perpétuo I; Rodrigues AM; Janeiro A; Costa MM; Gaião L; Pereira da Silva JA; Fonseca JE; Miltenberger-Miltenyi G
Semin Arthritis Rheum; 2014 Feb; 43(4):566-9. PubMed ID: 24012041
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6, tumor necrosis factor-alpha and receptor activator of nuclear factor kappa ligand are elevated in hypertrophic gastric mucosa of pachydermoperiostosis.
Huang H; Wang Y; Cao Y; Wu B; Li Y; Fan L; Tan Z; Jiang Y; Tang J; Hu J; Shi X
Sci Rep; 2017 Aug; 7(1):9686. PubMed ID: 28851954
[TBL] [Abstract][Full Text] [Related]
16. [Progress in genetic research on pachydermoperiostosis].
Du R; Fan L; Huang H; Xiang R
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Feb; 33(1):105-7. PubMed ID: 26829746
[TBL] [Abstract][Full Text] [Related]
17. Monoallelic mutations in SLCO2A1 cause autosomal dominant primary hypertrophic osteoarthropathy.
Xu Y; Zhang Z; Yue H; Li S; Zhang Z
J Bone Miner Res; 2021 Aug; 36(8):1459-1468. PubMed ID: 33852188
[TBL] [Abstract][Full Text] [Related]
18. Homozygous Missense Variant in the Solute Carrier Organic Anion Transporter 2A1 (
Umair M; Bilal M; Shah K; Said G; Ahmad F
Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833358
[TBL] [Abstract][Full Text] [Related]
19. [Genetic diagnosis for a Chinese Han family with primary hypertrophic osteoarthropathy].
Wang L; Yu J; Li Y; Liu X; Zhang Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Apr; 32(2):213-7. PubMed ID: 25863089
[TBL] [Abstract][Full Text] [Related]
20. A novel mutation in the SLCO2A1 gene in a Chinese family with primary hypertrophic osteoarthropathy.
Zhang Z; He JW; Fu WZ; Zhang CQ; Zhang ZL
Gene; 2013 May; 521(1):191-4. PubMed ID: 23531451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
